Alteration of CD39+Foxp3+ CD4 T cell and cytokine levels in EAE/MS following anti-CD52 treatment.
Pant AB, Wang Y, Mielcarz DW, Kasper EJ, Telesford KM, Mishra M, Haque A, Channon JY, Kasper LH, Begum-Haque S.
Pant AB, et al. Among authors: kasper lh, kasper ej.
J Neuroimmunol. 2017 Feb 15;303:22-30. doi: 10.1016/j.jneuroim.2016.12.010. Epub 2016 Dec 21.
J Neuroimmunol. 2017.
PMID: 28087077